Table 2.
Perioperative Findings and Management.
| Pathogen Isolated Intraoperatively | Adjuvant Antibiotic Treatment | ||
|---|---|---|---|
| Polymicrobial infection | 13 | Perioperative antibiotics | |
| Staphylococcus aureus | 10 | Intravenous broad spectrum after sampling | 24 |
| Coagulase-negative staphylococcus | 6 | Oral broad spectrum | 4 |
| Streptococcus spp | 6 | Postoperative antibiotics | |
| Proteus mirabilis | 4 | 6 wk; Intravenous then oral based on sensitivities | 18 |
| Enterococcus faecalis | 4 | 3 months; intravenous then oral based on sensitivities | 3 |
| Escherichia coli | 3 | 6 wk intravenous alone | 3 |
| Klebsiella spp | 2 | 6 wk oral alone | 3 |
| Enterobacter spp | 2 | 6 mo oral (anti-TB) | 1 |
| Corynebacterium striatum | 2 | Dead space management | |
| Streptococcus anginosus | 1 | CERAMENT + gentamicin |
13 |
| Diphtheroid spp. | 1 | OsteoSet + tobramycin | 2 |
| Pseudomonas aeruginosa | 1 | Collagen fleece | 2 |
| Candida sp | 1 | Gentamicin beads | 2 |
| Mycobacterium tuberculosis | 1 | Herafill beads + gentamicin | 1 |
| Morganella morganii | 1 | ||
| Soft tissue closure | |||
| Direct closure | 22 | ||
| Free flap + split skin graft | 3 | ||
| Keystone flap | 2 | ||
| Lateral calcaneal flap | 1 | ||